Global bond experts committed to ESG
Asian fixed income strategists with a commitment to sustainability, supported by 300 investment professionals across 11 major Asian markets
0% sales charges
Choose from hundreds of funds with no sales charges
100% Cashback on trailer fees
Lower your costs by up to 1% per year
Licensed by MAS, with assets are held in your own name at UOB Kay Hian
Eastspring Investments, part of Prudential PLC, is a global asset manager with Asia at its core, offering innovative investment solutions to meet the financial needs of clients. At the heart of Eastspring is a strong connection with our shared purpose – Experts in Asia. Invested in Your Future. – and this clearly guides everything we do.
Our investment teams’ deep understanding of Asian markets, paired with their global expertise, is our key differentiator. We are also firmly invested in the future of our clients, our colleagues, our partners, our shareholders and the communities in which we live and operate in.
Over the last 25 years, we have built an unparalleled on-the-ground presence in 11 Asian markets as well as distribution offices in North America and Europe. We manage a total of USD $248 billion across equity, fixed income, multi asset, quantitative and alternative strategies on behalf of institutional and individual investors globally.
As the asset manager of Prudential PLC, we benefit from the strength and stability of our A-rated parent company, which serves over 16 million life customers across Asia and Africa.
GLOBAL VISION, ASIAN INSIGHTS
The global expertise and experience of our investment teams, together with our deep understanding of Asian markets, companies and corporate culture allow us to convert our unique perspective into global investment solutions across various asset classes.
We combine rigorous analysis, a long-term mindset and robust risk management processes to deliver consistent performance over different market conditions.
Our team of highly experienced investment professionals has a singular focus to deliver superior long-term outcomes to investors.